Telemedicine Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Telemedicine Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Ludwig Boltzmann Institute for Surgical Endoscopy, Austria
Occult contralateral cancers' rarity may not warrant routine sentinel node mapping
September 13th, 2006
The rarity of occult contralateral cancers may not warrant routine sentinel node (SN) mapping in patients scheduled for contralateral reduction mammaplasty. "Occult invasive cancer found in reduction mammaplasty specimen in the contralateral breast in breast cancer patients requires axillary lymph node dissection (ALND) to assess the lymph node status. Routine SN biopsy in these patients may avoid secondary ALND when an occult cancer is found and the SN is negative in the permanent histological examination. One hundred sixty-nine breast cancer patients underwent contralateral reduction mammaplasty for symmetrization and with SN biopsy of the non-cancer breast,"...
Source: Telemedicine Business Week (2006-09-13)
|
